Correlation Between Monopar Therapeutics and ENCANA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and ENCANA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and ENCANA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and ENCANA P 65, you can compare the effects of market volatilities on Monopar Therapeutics and ENCANA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of ENCANA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and ENCANA.

Diversification Opportunities for Monopar Therapeutics and ENCANA

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monopar and ENCANA is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and ENCANA P 65 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENCANA P 65 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with ENCANA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENCANA P 65 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and ENCANA go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and ENCANA

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 39.16 times more return on investment than ENCANA. However, Monopar Therapeutics is 39.16 times more volatile than ENCANA P 65. It trades about 0.05 of its potential returns per unit of risk. ENCANA P 65 is currently generating about 0.02 per unit of risk. If you would invest  1,675  in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of  3,036  from holding Monopar Therapeutics or generate 181.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy82.56%
ValuesDaily Returns

Monopar Therapeutics  vs.  ENCANA P 65

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
ENCANA P 65 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ENCANA P 65 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ENCANA is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and ENCANA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and ENCANA

The main advantage of trading using opposite Monopar Therapeutics and ENCANA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, ENCANA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENCANA will offset losses from the drop in ENCANA's long position.
The idea behind Monopar Therapeutics and ENCANA P 65 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges